| Subject: | FDA Publishes Notice About Recalled Drugs from Able Laboratories |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 2 Jun 2005 - 10:00 am |
| The FDA has notified customers and healthcare professionals of a nationwide recall of all drugs (mostly generic prescription drugs, including drugs that contain acetaminophen) manufacturered by Able Laboratories of Cranbury, New Jersey. The recall was initiated due to serious concerns that the drugs were not produced according to quality standards. Able Laboratories has ceased all current production of drugs.
The FDA is continuing to evaluate the situation at Able... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
